Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Cancer Metastatic × raltitrexed × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 12 Rectal Neoplasms 9 Colonic Neoplasms 5 Unspecified Adult Solid Tumor, Protocol Specific 2 Stomach Neoplasms 2 Thrombocytopenia 1 Squamous Cell Carcinoma of Head and Neck 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Mesothelioma, Malignant 1 Liver, Cancer of, Primary Resectable 1 Inoperable Esophageal Cancer Stage I-III 1 Hepatocellular Carcinoma Resectable 1 Hepatecellular Carcinoma 1 Head and Neck Squamous Cell Cancer 1 Fruquintinib 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Cancer Metastatic 1 Colon Cancer Liver Metastasis 1 Carcinoma, Hepatocellular 1 Advanced Metastatic Colorectal Cancer 1 Advanced Gastric Cancer 1 Advanced Colorectal Carcinoma 1 Advanced Colorectal Cancer 1

Interventions

Bevacizumab 18 Capecitabine 15 Oxaliplatin 10 Cetuximab 10 Irinotecan 9 Fluorouracil 8 Panitumumab 6 Leucovorin 6 aflibercept 5 trifluridine tipiracil drug combination 3 sintilimab 3 regorafenib 3 Nivolumab 3 Vemurafenib 2 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 Ipilimumab 2 Drug Therapy 2 spartalizumab 1 raltitrexed 1 pembrolizumab 1 masitinib 1 irinotecan sucrosofate 1 folfirinox 1 camrelizumab 1 balstilimab 1 atezolizumab 1 anisodamine 1 XELOX 1 Tyrosine Kinase Inhibitors 1 Tomography, X-Ray Computed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01959061 2017-03-13

TACE

Nanjing Chia-tai Tianqing Pharmaceutical

Phase 4 Unknown

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡